Regulating Rho GTPases and their regulators

Nature Reviews Molecular Cell Biology

Volumn 17, Issue 8, 2016, Pages 496-510

  Hodge, Richard G ^a   Ridley, Anne J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

COMPLEX FORMATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; HUMAN; LIPID MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PRENYLATION; PROTEIN PROCESSING; REVIEW; SUMOYLATION; UBIQUITINATION; ANIMAL; METABOLISM;

ANIMALS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RHO GTP-BINDING PROTEINS;

EID: 84979285037     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm.2016.67     Document Type: Review

References (170)

1. Vega F. M., & Ridley A. J. Rho GTPases in cancer cell biology. FEBS Lett. 582, 2093-2101 (2008).
2. Heasman S. J., & Ridley A. J. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 9, 690-701 (2008).
3. Ridley A. J. Life at the leading edge. Cell 145, 1012-1022 (2011).
4. Rossman K. L., Der C. J., & Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell Biol. 6, 167-180 (2005).
5. Liu M., Bi F., Zhou X., & Zheng Y. Rho GTPase regulation by miRNAs and covalent modifications. Trends Cell Biol. 22, 365-373 (2012).
6. Croft D. R., & Olson M. F. Transcriptional regulation of Rho GTPase signaling. Transcription 2, 211-215 (2011).
7. Berthold J., Schenkova K., & Rivero F. Rho GTPases of the RhoBTB subfamily and tumorigenesis. Acta Pharmacol. Sin. 29, 285-295 (2008).
8. Michaelson D., et al. Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J. Cell Biol. 152, 111-126 (2001).
9. Katayama M., et al. The posttranslationally modified C terminal structure of bovine aortic smooth muscle rhoA p21. J. Biol. Chem. 266, 12639-12645 (1991).
10. Adamson P., Marshall C. J., Hall A., & Tilbrook P. A. Post-Translational modifications of p21rho proteins. J. Biol. Chem. 267, 20033-20038 (1992).
11. Hamel B., et al. SmgGDS is A guanine nucleotide exchange factor that specifically activates RhoA and RhoC. J. Biol. Chem. 286, 12141-12148 (2011).
12. Berg T. J., et al. Splice variants of SmgGDS control small GTPase prenylation and membrane localization. J. Biol. Chem. 285, 35255-35266 (2010).
13. Wang D. A., & Sebti S. M. Palmitoylated cysteine 192 is required for RhoB tumor-suppressive and apoptotic activities. J. Biol. Chem. 280, 19243-19249 (2005).
14. Perez-Sala D., Boya P., Ramos I., Herrera M., & Stamatakis K. The C terminal sequence of RhoB directs protein degradation through an endo lysosomal pathway. PLoS ONE 4, e8117 (2009).
15. Berzat A. C., et al. Transforming activity of the Rho family GTPase Wrch 1, A Wnt-regulated Cdc42 homolog, is dependent on A novel carboxyl-Terminal palmitoylation motif. J. Biol. Chem. 280, 33055-33065 (2005).
16. Chenette E. J., Mitin N. Y., & Der C. J. Multiple sequence elements facilitate Chp Rho GTPase subcellular location, membrane association, and transforming activity. Mol. Biol. Cell 17, 3108-3121 (2006).
17. Linder M. E., & Deschenes R. J. Palmitoylation: policing protein stability and traffic. Nat. Rev. Mol. Cell Biol. 8, 74-84 (2007).
18. Rocks O., et al. The palmitoylation machinery is A spatially organizing system for peripheral membrane proteins. Cell 141, 458-471 (2010).
19. Navarro-Lerida I., et al. A palmitoylation switch mechanism regulates Rac1 function and membrane organization. EMBO J. 31, 534-551 (2012).
20. Nishimura A., & Linder M. E. Identification of A novel prenyl and palmitoyl modification at the CaaX motif of Cdc42 that regulates RhoGDI binding. Mol. Cell. Biol. 33, 1417-1429 (2013).
21. Lang P., et al. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J. 15, 510-519 (1996).
22. Tkachenko E., et al. Protein kinase A governs A RhoA-RhoGDI protrusion-retraction pacemaker in migrating cells. Nat. Cell Biol. 13, 660-667 (2011).
23. Ellerbroek S. M., Wennerberg K., & Burridge K. Serine phosphorylation negatively regulates RhoA in vivo. J. Biol. Chem. 278, 19023-19031 (2003).
24. Sauzeau V., et al. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J. Biol. Chem. 275, 21722-21729 (2000).
25. Forget M., Desrosiers R. R., Gingras D., & Beliveau R. Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes. Biochem. J. 361, 243-254 (2002).
26. Takemoto K., Ishihara S., Mizutani T., Kawabata K., & Haga H. Compressive stress induces dephosphorylation of the myosin regulatory light chain via RhoA phosphorylation by the adenylyl cyclase/ protein kinase A signaling pathway. PLoS ONE 10, e0117937 (2015).
27. Nusser N., et al. Serine phosphorylation differentially affects RhoA binding to effectors: implications to NGF induced neurite outgrowth. Cell Signal 18, 704-714 (2006).
28. Rolli-Derkinderen M., Toumaniantz G., Pacaud P., & Loirand G. RhoA phosphorylation induces Rac1 release from guanine dissociation inhibitor α and stimulation of vascular smooth muscle cell migration. Mol. Cell. Biol. 30, 4786-4796 (2010).
29. Rolli-Derkinderen M., et al. Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells. Circ. Res. 96, 1152-1160 (2005).
30. Chang F., Lemmon C., Lietha D., Eck M., & Romer L. Tyrosine phosphorylation of Rac1: A role in regulation of cell spreading. PLoS ONE 6, e28587 (2011).
31. Kwon T., Kwon D. Y., Chun J., Kim J. H., & Kang S. S. Akt protein kinase inhibits Rac1 GTP binding through phosphorylation at serine 71 of Rac1. J. Biol. Chem. 275, 423-428 (2000).
32. Tong J., Li L., Ballermann B., & Wang Z. Phosphorylation of Rac1 T108 by extracellular signal-regulated kinase in response to epidermal growth factor: A novel mechanism to regulate Rac1 function. Mol. Cell. Biol. 33, 4538-4551 (2013).
33. Navarro-Lerida I., et al. Rac1 nucleocytoplasmic shuttling drives nuclear shape changes and tumor invasion. Dev. Cell 32, 318-334 (2015).
34. Jamieson C., Lui C., Brocardo M. G., Martino-Echarri E., & Henderson B. R. Rac1 augments Wnt signaling by stimulating β catenin-lymphoid enhancer factor 1 complex assembly independent of β catenin nuclear import. J. Cell Sci. 128, 3933-3946 (2015).
35. Cuadrado A., Martin-Moldes Z., Ye J., & Lastres Becker I. Transcription factors NRF2 and NF κB are coordinated effectors of the Rho family GTP-binding protein RAC1 during inflammation. J. Biol. Chem. 289, 15244-15258 (2014).
36. Riento K., et al. RhoE function is regulated by ROCK I mediated phosphorylation. EMBO J. 24, 1170-1180 (2005).
37. Madigan J. P., et al. Regulation of Rnd3 localization and function by protein kinase Cα-mediated phosphorylation. Biochem. J. 424, 153-161 (2009).
38. Riou P., et al. 14 3 3 proteins interact with A hybrid prenyl-phosphorylation motif to inhibit G proteins. Cell 153, 640-653 (2013).
39. Alan J. K., Berzat A. C., Dewar B. J., Graves L. M., & Cox A. D. Regulation of the Rho family small GTPase Wrch 1/RhoU by C terminal tyrosine phosphorylation requires Src. Mol. Cell. Biol. 30, 4324-4338 (2010).
40. Tamehiro N., Oda H., Shirai M., & Suzuki H. Overexpression of RhoH permits to bypass the pre TCR checkpoint. PLoS ONE 10, e0131047 (2015).
41. Gu Y., et al. RhoH GTPase recruits and activates Zap70 required for T cell receptor signaling and thymocyte development. Nat. Immunol. 7, 1182-1190 (2006).
42. Riou P., Villalonga P., & Ridley A. J. Rnd proteins: multifunctional regulators of the cytoskeleton and cell cycle progression. Bioessays 32, 986-992 (2010).
43. Hornbeck P. V., et al. PhosphoSitePlus, 2014: mutations PTMs and recalibrations. Nucleic Acids Res. 43, 512-520 (2015).
44. Komander D., & Rape M. The ubiquitin code. Annu. Rev. Biochem. 81, 203-229 (2012).
45. Deng S., & Huang C. E3 ubiquitin ligases in regulating stress fiber, lamellipodium, and focal adhesion dynamics. Cell Adh. Migr. 8, 49-54 (2014).
46. Deshaies R. J., & Joazeiro C. A. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434 (2009).
47. Wei J., et al. A new mechanism of RhoA ubiquitination and degradation: Roles of SCFFBXL19 E3 ligase and Erk2. Biochim. Biophys. Acta 1833, 2757-2764 (2013).
48. Wang H., et al. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 302, 1775-1779 (2003).
49. Ozdamar B., et al. Regulation of the polarity protein Par6 by TGFB receptors controls epithelial cell plasticity. Science 307, 1603-1609 (2005).
50. Tian M., et al. Binding of RhoA by the C2 domain of E3 ligase Smurf1 is essential for Smurf1 regulated RhoA ubiquitination and cell protrusive activity. FEBS Lett. 585, 2199-2204 (2011).
51. Deglincerti A., et al. Coupled local translation and degradation regulate growth cone collapse. Nat. Commun. 6, 6888 (2015).
52. Chen Y., et al. Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. Mol. Cell 35, 841-855 (2009).
53. Ibeawuchi S. R., Agbor L. N., Quelle F. W., & Sigmund C. D. Hypertension-causing mutations in Cullin3 protein impair RhoA protein ubiquitination and augment the association with substrate adaptors. J. Biol. Chem. 290, 19208-19217 (2015).
54. Yu L., et al. SND1 acts downstream of TGFβ1 and upstream of Smurf1 to promote breast cancer metastasis. Cancer Res. 75, 1275-1286 (2015).
55. Cheng P. L., Lu H., Shelly M., Gao H., & Poo M. M. Phosphorylation of E3 ligase Smurf1 switches its substrate preference in support of axon development. Neuron 69, 231-243 (2011).
56. Wang M., et al. ATR/Chk1/Smurf1 pathway determines cell fate after DNA damage by controlling RhoB abundance. Nat. Commun. 5, 4901 (2014).
57. Berthold J., et al. Characterization of RhoBTB-dependent Cul3 ubiquitin ligase complexes-evidence for an autoregulatory mechanism. Exp. Cell Res. 314, 3453-3465 (2008).
58. Wilkins A., Ping Q., & Carpenter C. L. RhoBTB2 is A substrate of the mammalian Cul3 ubiquitin ligase complex. Genes Dev. 18, 856-861 (2004).
59. Oberoi T. K., et al. IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation. EMBO J. 31, 14-28 (2012).
60. Oberoi-Khanuja T. K., & Rajalingam K. IAPs as E3 ligases of Rac1: shaping the move. Small GTPases 3, 131-136 (2012).
61. Torrino S., et al. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1. Dev. Cell 21, 959-965 (2011).
62. Castillo-Lluva S., Tan C. T., Daugaard M., Sorensen P. H., & Malliri A. The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation. Oncogene 32, 1735-1742 (2013).
63. Mettouchi A., & Lemichez E. Ubiquitylation of active Rac1 by the E3 ubiquitin-ligase HACE1. Small GTPases 3, 102-106 (2012).
64. Goka E. T., & Lippman M. E. Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression. Oncogene 34, 5395-5405 (2015).
65. Zhao J., et al. SCF E3 ligase F box protein complex SCFFBXL19 regulates cell migration by mediating Rac1 ubiquitination and degradation. FASEB J. 27, 2611-2619 (2013).
66. Dong S., et al. F box protein complex FBXL19 regulates TGF β1 induced E cadherin down-regulation by mediating Rac3 ubiquitination and degradation. Mol. Cancer 13, 1-13 (2014).
67. Castillo-Lluva S., et al. SUMOylation of the GTPase Rac1 is required for optimal cell migration. Nat. Cell Biol. 12, 1078-1085 (2010).
68. Goicoechea S. M., Awadia S., & Garcia-Mata R. I?m coming to GEF you: Regulation of RhoGEFs during cell migration. Cell Adh. Migr. 8, 535-549 (2014).
69. Laurin M., & Cote J. F. Insights into the biological functions of Dock family guanine nucleotide exchange factors. Genes Dev. 28, 533-547 (2014).
70. Bustelo X. R. Vav family exchange factors: an integrated regulatory and functional view. Small GTPases 5, e973757 (2014).
71. Fujishiro S. H., et al. ERK1/2 phosphorylate GEF H1 to enhance its guanine nucleotide exchange activity toward RhoA. Biochem. Biophys. Res. Commun. 368, 162-167 (2008).
72. Kakiashvili E., et al. GEF H1 mediates tumor necrosis factor-α induced Rho activation and myosin phosphorylation: role in the regulation of tubular paracellular permeability. J. Biol. Chem. 284, 11454-11466 (2009).
73. Guilluy C., et al. The Rho GEFs LARG and GEF H1 regulate the mechanical response to force on integrins. Nat. Cell Biol. 13, 722-727 (2011).
74. Zenke F. T., et al. p21 activated kinase 1 phosphorylates and regulates 14 3 3 binding to GEF H1, A microtubule-localized Rho exchange factor. J. Biol. Chem. 279, 18392-18400 (2004).
75. Ngok S. P., Geyer R., Kourtidis A., Storz P., & Anastasiadis P. Z. Phosphorylation-mediated 14 3 3 protein binding regulates the function of the Rho-specific guanine nucleotide exchange factor (RhoGEF) Syx. J. Biol. Chem. 288, 6640-6650 (2013).
76. Zhu G., et al. An EGFR/PI3K/AKT axis promotes accumulation of the Rac1 GEF Tiam1 that is critical in EGFR-driven tumorigenesis. Oncogene 34, 5971-5982 (2015).
77. O?Toole T. E., Bialkowska K., Li X., & Fox J. E. Tiam1 is recruited to β1 integrin complexes by 14 3 3? where it mediates integrin-induced Rac1 activation and motility. J. Cell. Physiol. 226, 2965-2978 (2011).
78. Magliozzi R., Kim J., Low T. Y., Heck A. J., & Guardavaccaro D. Degradation of Tiam1 by casein kinase 1 and the SCFβTrCP ubiquitin ligase controls the duration of mTOR S6K signaling. J. Biol. Chem. 289, 27400-27409 (2014).
79. Whalley H. J., et al. Cdk1 phosphorylates the Rac activator Tiam1 to activate centrosomal Pak and promote mitotic spindle formation. Nat. Commun. 6, 7437 (2015).
80. Woodcock S. A., et al. SRC-induced disassembly of adherens junctions requires localized phosphorylation and degradation of the Rac activator Tiam1. Mol. Cell 33, 639-653 (2009).
81. Birkenfeld J., et al. GEF H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases. Dev. Cell 12, 699-712 (2007).
82. Helms M. C., et al. Mitotic-dependent phosphorylation of leukemia-Associated RhoGEF (LARG) by Cdk1. Cell Signal. 28, 43-52 (2015).
83. Wu D., Asiedu M., Matsumura F., & Wei Q. Phosphorylation of myosin II interacting guanine nucleotide exchange factor (MyoGEF) at threonine 544 by aurora B kinase promotes the binding of polo-like kinase 1 to MyoGEF. J. Biol. Chem. 289, 7142-7150 (2014).
84. Miyamoto Y., et al. Akt and PP2A reciprocally regulate the guanine nucleotide exchange factor Dock6 to control axon growth of sensory neurons. Sci. Signal. 6, 1-12 (2013).
85. Vaughan L., et al. HUWE1 ubiquitylates and degrades the RAC activator TIAM1 promoting cell-cell adhesion disassembly, migration, and invasion. Cell Rep. 10, 88-102 (2015).
86. Margolis S. S., et al. EphB-mediated degradation of the RhoA GEF Ephexin5 relieves A developmental brake on excitatory synapse formation. Cell 143, 442-455 (2010).
87. Song E. H., et al. Acetylation of the RhoA GEF Net1A controls its subcellular localization and activity. J. Cell Sci. 128, 913-922 (2015).
88. Radu M., Semenova G., Kosoff R., & Chernoff J. PAK signalling during the development and progression of cancer. Nat. Rev. Cancer 14, 13-25 (2013).
89. Tian Y., et al. Hepatocyte growth factor-induced Asef IQGAP1 complex controls cytoskeletal remodeling and endothelial barrier. J. Biol. Chem. 290, 4097-4109 (2015).
90. Marei H., et al. Differential Rac1 signalling by guanine nucleotide exchange factors implicates FLII in regulating Rac1 driven cell migration. Nat. Commun. 7, 10664 (2016).
91. Toret C. P., Collins C., & Nelson W. J. An Elmo-Dock complex locally controls Rho GTPases and actin remodeling during cadherin-mediated adhesion. J. Cell Biol. 207, 577-587 (2014).
92. Carr H. S., Cai C., Keinanen K., & Frost J. A. Interaction of the RhoA exchange factor Net1 with discs large homolog 1 protects it from proteasome-mediated degradation and potentiates Net1 activity. J. Biol. Chem. 284, 24269-24280 (2009).
93. Garcia-Mata R., et al. The nuclear RhoA exchange factor Net1 interacts with proteins of the Dlg family, affects their localization, and influences their tumor suppressor activity. Mol. Cell. Biol. 27, 8683-8697 (2007).
94. Razidlo G. L., et al. Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1. Dev. Cell 24, 573-585 (2013).
95. Chikumi H., et al. Homo-And hetero-oligomerization of PDZ-RhoGEF, LARG and p115RhoGEF by their C terminal region regulates their in vivo Rho GEF activity and transforming potential. Oncogene 23, 233-240 (2004).
96. Baisamy L., Jurisch N., & Diviani D. Leucine zipper mediated homo-oligomerization regulates the Rho-GEF activity of AKAP-Lbc. J. Biol. Chem. 280, 15405-15412 (2005).
97. Moon S. Y., & Zheng Y. Rho GTPase-Activating proteins in cell regulation. Trends Cell Biol. 13, 13-22 (2003).
98. Peck J., Douglas G. 4th Wu C. H., & Burbelo P. D. Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships. FEBS Lett. 528, 27-34 (2002).
99. Kim T. Y., et al. CRL4A FBXW5 mediated degradation of DLC1 Rho GTPase-Activating protein tumor suppressor promotes non-small cell lung cancer cell growth. Proc. Natl Acad. Sci. USA 110, 16868-16873 (2013).
100. Ko F. C., et al. PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis. Nat. Commun. 4, 1618 (2013).
101. Tripathi B. K., et al. CDK5 is A major regulator of the tumor suppressor DLC1. J. Cell Biol. 207, 627-642 (2014).
102. Morishita Y., Tsutsumi K., & Ohta Y. Phosphorylation of serine 402 regulates RacGAP activity of FilGAP. J. Biol. Chem. 290, 26328-26338 (2015).
103. Kannan M., Lee S. J., Schwedhelm-Domeyer N., Nakazawa T., & Stegmuller J. p250GAP is A novel player in the Cdh1 APC/Smurf1 pathway of axon growth regulation. PLoS ONE 7, e50735 2012).
104. Bigarella C. L., et al. Post-Translational modification of the RhoGTPase activating protein 21, ARHGAP21, by SUMO2/3. FEBS Lett. 586, 3522-3528 (2012).
105. Endris V., et al. SrGAP3 interacts with lamellipodin at the cell membrane and regulates Rac-dependent cellular protrusions. J. Cell Sci. 124, 3941-3955 (2011).
106. Law A. L., et al. Lamellipodin and the Scar/WAVE complex cooperate to promote cell migration in vivo. J. Cell Biol. 203, 673-689 (2013).
107. Zebda N., et al. Interaction of p190RhoGAP with C terminal domain of p120 catenin modulates endothelial cytoskeleton and permeability. J. Biol. Chem. 288, 18290-18299 (2013).
108. Shih Y. P., Sun P., Wang A., & Lo S. H. Tensin1 positively regulates RhoA activity through its interaction with DLC1. Biochim. Biophys. Acta 1853, 3258-3265 (2015).
109. Kawai K., Kitamura S. Y., Maehira K., Seike J., & Yagisawa H. START GAP1/DLC1 is localized in focal adhesions through interaction with the PTB domain of tensin2. Adv. Enzyme Regul. 50, 202-215 (2010).
110. Chan L. K., Ko F. C., Ng I. O., & Yam J. W. Deleted in liver cancer 1 (DLC1) utilizes A novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function. PLoS ONE 4, e5572 (2009).
111. Cao X., et al. A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration. Nat. Commun. 6, 7721 (2015).
112. Campa C. C., Ciraolo E., Ghigo A., Germena G., & Hirsch E. Crossroads of PI3K and Rac pathways. Small GTPases 6, 71-80 (2015).
113. Huang T. Y., et al. A novel Rac1 GAP splice variant relays poly Ub accumulation signals to mediate Rac1 inactivation. Mol. Biol. Cell 24, 194-209 (2013).
114. Um K., et al. Dynamic control of excitatory synapse development by A Rac1 GEF/GAP regulatory complex. Dev. Cell 29, 701-715 (2014).
115. Kutys M. L., & Yamada K. M. An extracellular-matrix-specific GEF-GAP interaction regulates Rho GTPase crosstalk for 3D collagen migration. Nat. Cell Biol. 16, 909-917 (2014).
116. Abraham S., et al. A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis. Nat. Commun. 6, 7286 (2015).
117. Vaughan E. M., Miller A. L., Yu H. Y., & Bement W. M. Control of local Rho GTPase crosstalk by Abr. Curr. Biol. 21, 270-277 (2011).
118. Garcia-Mata R., Boulter E., & Burridge K. The ?invisible hand?: regulation of RHO GTPases by RHOGDIs. Nat. Rev. Mol. Cell Biol. 12, 493-504 (2011).
119. Hoffman G. R., Nassar N., & Cerione R. A. Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 100, 345-356 (2000).
120. Johnson J. L., Erickson J. W., & Cerione R. A. New insights into how the Rho guanine nucleotide dissociation inhibitor regulates the interaction of Cdc42 with membranes. J. Biol. Chem. 284, 23860-23871 (2009).
121. DerMardirossian C., Rocklin G., Seo J. Y., & Bokoch G. M. Phosphorylation of RhoGDI by Src regulates Rho GTPase binding and cytosol-membrane cycling. Mol. Biol. Cell 17, 4760-4768 (2006).
122. Dovas A., et al. Serine 34 phosphorylation of Rho guanine dissociation inhibitor (RhoGDIα) links signaling from conventional protein kinase C to RhoGTPase in cell adhesion. J. Biol. Chem. 285, 23296-23308 (2010).
123. Sabbatini M. E., & Williams J. A. Cholecystokinin-mediated RhoGDI phosphorylation via PKCα promotes both RhoA and Rac1 signaling. PLoS ONE 8, e66029 (2013).
124. DerMardirossian C., Schnelzer A., & Bokoch G. M. Phosphorylation of RhoGDI by Pak1 mediates dissociation of Rac GTPase. Mol. Cell 15, 117-127 (2004).
125. Fei F., et al. The Fer tyrosine kinase regulates interactions of Rho GDP-Dissociation Inhibitor α with the small GTPase Rac. BMC Biochem. 11, 48 (2010).
126. Oishi A., Makita N., Sato J., & Iiri T. Regulation of RhoA signaling by the cAMP-dependent phosphorylation of RhoGDIα. J. Biol. Chem. 287, 38705-38715 (2012).
127. Yu J., et al. RhoGDI SUMOylation at Lys 138 increases its binding activity to Rho GTPase and its inhibiting cancer cell motility. J. Biol. Chem. 287, 13752-13760 (2012).
128. Cao Z., et al. SUMOylation of RhoGDIα is required for its repression of cyclin D1 expression and anchorage-independent growth of cancer cells. Mol. Oncol. 8, 285-296 (2014).
129. Liu J., et al. X linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton. J. Biol. Chem. 286, 15630-15640 (2011).
130. Xiao Y., et al. 14 3 3? promotes breast cancer invasion and metastasis by inhibiting RhoGDIα. Mol. Cell. Biol. 34, 2635-2649 (2014).
131. Pu J., et al. FERM domain containing protein 7 interacts with the Rho GDP dissociation inhibitor and specifically activates Rac1 signaling. PLoS ONE 8, e73108 (2013).
132. Lu Y., et al. TROY interacts with Rho guanine nucleotide dissociation inhibitor α (RhoGDIα) to mediate Nogo-induced inhibition of neurite outgrowth. J. Biol. Chem. 288, 34276-34286 (2013).
133. Dart A. E., et al. PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion. J. Cell Biol. 211, 863-879 (2015).
134. Schuld N. J., et al. The chaperone protein SmgGDS interacts with small GTPases entering the prenylation pathway by recognizing the last amino acid in the CAAX motif. J. Biol. Chem. 289, 6862-6876 (2014).
135. Ntantie E., et al. An adenosine-mediated signaling pathway suppresses prenylation of the GTPase Rap1B and promotes cell scattering. Sci. Signal. 6, 1-10 (2013).
136. Flotho A., & Melchior F. Sumoylation: A regulatory protein modification in health and disease. Annu. Rev. Biochem. 82, 357-385 (2013).
137. Tu S., Wu W. J., Wang J., & Cerione R. A. Epidermal growth factor-dependent regulation of Cdc42 is mediated by the Src tyrosine kinase. J. Biol. Chem. 278, 49293-49300 (2003).
138. Okada S., et al. CDK5 dependent phosphorylation of the Rho family GTPase TC10α regulates insulin-stimulated GLUT4 translocation. J. Biol. Chem. 283, 35455-35463 (2008).
139. Guilluy C., et al. Ste20 related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II type 2 receptor activation. Circ. Res. 102, 1265-1274 (2008).
140. Bryan B., et al. Ubiquitination of RhoA by Smurf1 promotes neurite outgrowth. FEBS Lett. 579, 1015-1019 (2005).
141. Li H., et al. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-To mesenchymal transition in part through the RhoA signaling pathway in gastric cancer. Cancer Lett. 370, 39-55 (2015).
142. Tillement V., et al. Phosphorylation of RhoB by CK1 impedes actin stress fiber organization and epidermal growth factor receptor stabilization. Exp. Cell Res. 314, 2811-2821 (2008).
143. Xu J., et al. The neddylation-cullin 2-RBX1 E3 ligase axis targets tumor suppressor RhoB for degradation in liver cancer. Mol. Cell. Proteomics 14, 499-509 (2015).
144. Lehman H. L., et al. Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase. Mol. Cancer. Res. 10, 1306-1318 (2012).
145. Lonjedo M., et al. The Rho family member RhoE interacts with Skp2 and is degraded at the proteasome during cell cycle progression. J. Biol. Chem. 288, 30872-30882 (2013).
146. Duan L., et al. Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration. J. Biol. Chem. 286, 620-633 (2011).
147. Genau H. M., et al. CUL3 KBTBD6/KBTBD7 ubiquitin ligase cooperates with GABARAP proteins to spatially restrict TIAM1-RAC1 signaling. Mol. Cell 57, 995-1010 (2015).
148. Chikumi H., Fukuhara S., & Gutkind J. S. Regulation of G protein-linked guanine nucleotide exchange factors for Rho PDZ-RhoGEF, and LARG by tyrosine phosphorylation: evidence of A role for focal adhesion kinase. J. Biol. Chem. 277, 12463-12473 (2002).
149. Yang Y., et al. CYLD regulates RhoA activity by modulating LARG ubiquitination. PLoS ONE 8, e55833 (2013).
150. Yamahashi Y., Saito Y., Murata-Kamiya N., & Hatakeyama M. Polarity-regulating kinase partitioning-defective 1b (PAR1b) phosphorylates guanine nucleotide exchange factor H1 (GEF H1) to regulate RhoA-dependent actin cytoskeletal reorganization. J. Biol. Chem. 286, 44576-44584 (2011).
151. Gupta M., Qi X., Thakur V., & Manor D. Tyrosine phosphorylation of Dbl regulates GTPase signaling. J. Biol. Chem. 289, 17195-17202 (2014).
152. Kamynina E., Kauppinen K., Duan F., Muakkassa N., & Manor D. Regulation of proto-oncogenic Dbl by chaperone-controlled, ubiquitin-mediated degradation. Mol. Cell. Biol. 27, 1809-1822 (2007).
153. Justilien V., Jameison L., Der C. J., Rossman K. L., & Fields A. P. Oncogenic activity of Ect2 is regulated through protein kinase C? mediated phosphorylation. J. Biol. Chem. 286, 8149-8157 (2011).
154. Liot C., et al. APCcdh1 mediates degradation of the oncogenic Rho-GEF Ect2 after mitosis. PLoS ONE 6, e23676 (2011).
155. Barac A., et al. Direct interaction of p21 activated kinase 4 with PDZ-RhoGEF, A G protein-linked Rho guanine exchange factor. J. Biol. Chem. 279, 6182-6189 (2004).
156. Lin M. Y., Lin Y. M., Kao T. C., Chuang H. H., & Chen R. H. PDZ-RhoGEF ubiquitination by Cullin3 KLHL20 controls neurotrophin-induced neurite outgrowth. J. Cell Biol. 193, 985-994 (2011).
157. Scholz R. P., et al. The tumor suppressor protein DLC1 is regulated by PKD-mediated GAP domain phosphorylation. Exp. Cell Res. 317, 496-503 (2011).
158. Ravi A., Kaushik S., Ravichandran A., Pan C. Q., & Low B. C. Epidermal growth factor activates the Rho GTPase-Activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A. J. Biol. Chem. 290, 4149-4162 (2015).
159. Danek E. I., Tcherkezian J., Triki I., Meriane M., & Lamarche-Vane N. Glycogen synthase kinase 3 phosphorylates CdGAP at A consensus ERK1 regulatory site. J. Biol. Chem. 282, 3624-3631 (2007).
160. Tcherkezian J., Danek E. I., Jenna S., Triki I., & Lamarche-Vane N. Extracellular signal-regulated kinase 1 interacts with and phosphorylates CdGAP at an important regulatory site. Mol. Cell. Biol. 25, 6314-6329 (2005).
161. Minoshima Y., et al. Phosphorylation by Aurora B kinase converts MgcRacGAP to A RhoGAP during cytokinesis. Dev. Cell 4, 549-560 (2003).
162. Nishimura K., et al. APCCDH1 targets MgcRacGAP for destruction in the late M phase. PLoS ONE 8, e63001 (2013).
163. Jiang W., et al. An FF domain-dependent protein interaction mediates A signaling pathway for growth factor-induced gene expression. Mol. Cell 17, 23-35 (2005).
164. Mori K., et al. Rho-kinase contributes to sustained RhoA activation through phosphorylation of p190A RhoGAP. J. Biol. Chem. 284, 5067-5076 (2009).
165. Jiang W., et al. p190A RhoGAP is A glycogen synthase kinase 3 β substrate required for polarized cell migration. J. Biol. Chem. 283, 20978-20988 (2008).
166. Pullikuth A. K., & Catling A. D. Extracellular signal-regulated kinase promotes Rho-dependent focal adhesion formation by suppressing p190A RhoGAP. Mol. Cell. Biol. 30, 3233-3248 (2010).
167. Naoe H., et al. The anaphase-promoting complex/ cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation. Mol. Cell. Biol. 30, 3994-4005 (2010).
168. Su L., Lineberry N., Huh Y., Soares L., & Fathman C. G. A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as A substrate of gene related to anergy in lymphocytes. J. Immunol. 177, 7559-7566 (2006).
169. Wu Y., et al. Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function. Proc. Natl Acad. Sci. USA 106, 5807-5812 (2009).
170. Griner E. M., Churchill M. E., Brautigan D. L., & Theodorescu D. PKCα phosphorylation of RhoGDI2 at Ser31 disrupts interactions with Rac1 and decreases GDI activity. Oncogene 32, 1010-1017 (2013).